Elixinol Wellness Limited

Strategic Acquisition and Capital Raising - Investor Presentation | 3 October 2024

Elixinol Wellness Ltd. (”EXL”) has entered into a binding agreement to acquire 100% of the business assets from the entities ("Acquisition") that together form The Healthy Chef business ("Healthy Chef").


ACQUISITION PURCHASE PRICE

  • The aggregate total Purchase Price will be between $3.1 million - $5.5 million, with the final amount determined on1st March 2028(Final Settlement). ThePurchase Price willbe calculated on a sliding scale with a minimum of $3.1 million and a maximum of $5.5 million if the grossrevenue generated by Healthy Chef in Financial Year 2027 is over $10 million.
  • ThePurchase Price comprises:

a) Ordinary Shares in EXLto the valueof $400,000 (Consideration Shares), calculated at 30-day VWAP on 10 September, subject to shareholder approval and under a 12-month escrow period

b) The remainder of the Purchase Price to be paid incash according tothe agreed Deferred Payment Schedule

DEFERRED PAYMENT SCHEDULE

  • EXL agrees to pay Healthy Chef:

a) $600,000 in upfront cash at the closing of the proposed Transaction (Completion)

b) $450,000 in cash on the 1st annual anniversary of Completion

c) $600,000 in cash on the 2nd annual anniversary of Completion

d) The remainder of the Purchase Price to be paid in cash on the Final Settlement date

FUNDING

  • Funding of the Acquisition will consist of:

a) A single-tranche placement of $1.1 millionand Share PurchasePlan (SPP) to raise up to $0.5 million

b) Canaccord Genuity is acting as Lead Manager to the Equity Raising, see Pg. 25 for details

c) Deferred consideration is anticipated to be funded from operational cashflow

Click here for the full ASX Release

This article includes content from Elixinol Wellness Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

The Conversation (0)

Latest Press Releases

Related News

×